Global Peptide CDMO Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Description

According to our (Global Info Research) latest study, the global Peptide CDMO market size was valued at USD 3265.7 million in 2022 and is forecast to a readjusted size of USD 8327.1 million by 2029 with a CAGR of 14.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global key peptide CDMO producers include Bachem, PolyPeptide, CordenPharma, and others. The top five manufacturers together account for 40% of the market share, with the largest manufacturer being Bachem with 17%. At the sales level, North America is the largest sales market with a market share of over 50%, followed by Europe and China with 33% and 9% respectively. In terms of product categories, it is divided into APIs and intermediates and FDF, with the former holding the major market share of 67%. In terms of application, commercial is the top application area with a market share of 76%, followed by academic research institutions.

Peptides are synthesized by coupling the carboxyl group of one amino acid to the amino group of another amino acid molecule. Due to the possibility of unintended reactions, protecting groups are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.

A contract development and manufacturing company (CDMO) is a company within the pharmaceutical industry that provides drug development and manufacturing services. Pharmaceutical companies partner with CDMOs as a way to outsource drug development and drug manufacturing.

CDMO peptides production via contract peptide manufacturing is to optimize process development and achieve highly efficient conversion at every amino acid coupling to produce a high-purity crude synthetic custom peptide and minimize the demands on downstream processing.

This report is a detailed and comprehensive analysis for global Peptide CDMO market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Peptide CDMO market size and forecasts, in consumption value ($ Million), 2018-2029
Global Peptide CDMO market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Peptide CDMO market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Peptide CDMO market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Peptide CDMO
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Peptide CDMO market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bachem, PolyPeptide, CordenPharma, AmbioPharm and USV Peptides, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Peptide CDMO market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    APIs and Intermediates
    FDF

Market segment by Application
    Commercial
    Academic Research
    Other

Market segment by players, this report covers
    Bachem
    PolyPeptide
    CordenPharma
    AmbioPharm
    USV Peptides
    Thermofischer
    Bio Basic
    JPT
    Genscript
    Xinbang Pharma
    ScinoPharm
    SN Biopharm
    CBL
    Piramal Pharma
    CPC Scientific

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Peptide CDMO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Peptide CDMO, with revenue, gross margin and global market share of Peptide CDMO from 2018 to 2023.
Chapter 3, the Peptide CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Peptide CDMO market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Peptide CDMO.
Chapter 13, to describe Peptide CDMO research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Peptide CDMO
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Peptide CDMO by Type
        1.3.1 Overview: Global Peptide CDMO Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Peptide CDMO Consumption Value Market Share by Type in 2022
        1.3.3 APIs and Intermediates
        1.3.4 FDF
    1.4 Global Peptide CDMO Market by Application
        1.4.1 Overview: Global Peptide CDMO Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Commercial
        1.4.3 Academic Research
        1.4.4 Other
    1.5 Global Peptide CDMO Market Size & Forecast
    1.6 Global Peptide CDMO Market Size and Forecast by Region
        1.6.1 Global Peptide CDMO Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Peptide CDMO Market Size by Region, (2018-2029)
        1.6.3 North America Peptide CDMO Market Size and Prospect (2018-2029)
        1.6.4 Europe Peptide CDMO Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Peptide CDMO Market Size and Prospect (2018-2029)
        1.6.6 South America Peptide CDMO Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Peptide CDMO Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Bachem
        2.1.1 Bachem Details
        2.1.2 Bachem Major Business
        2.1.3 Bachem Peptide CDMO Product and Solutions
        2.1.4 Bachem Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Bachem Recent Developments and Future Plans
    2.2 PolyPeptide
        2.2.1 PolyPeptide Details
        2.2.2 PolyPeptide Major Business
        2.2.3 PolyPeptide Peptide CDMO Product and Solutions
        2.2.4 PolyPeptide Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 PolyPeptide Recent Developments and Future Plans
    2.3 CordenPharma
        2.3.1 CordenPharma Details
        2.3.2 CordenPharma Major Business
        2.3.3 CordenPharma Peptide CDMO Product and Solutions
        2.3.4 CordenPharma Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 CordenPharma Recent Developments and Future Plans
    2.4 AmbioPharm
        2.4.1 AmbioPharm Details
        2.4.2 AmbioPharm Major Business
        2.4.3 AmbioPharm Peptide CDMO Product and Solutions
        2.4.4 AmbioPharm Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 AmbioPharm Recent Developments and Future Plans
    2.5 USV Peptides
        2.5.1 USV Peptides Details
        2.5.2 USV Peptides Major Business
        2.5.3 USV Peptides Peptide CDMO Product and Solutions
        2.5.4 USV Peptides Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 USV Peptides Recent Developments and Future Plans
    2.6 Thermofischer
        2.6.1 Thermofischer Details
        2.6.2 Thermofischer Major Business
        2.6.3 Thermofischer Peptide CDMO Product and Solutions
        2.6.4 Thermofischer Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Thermofischer Recent Developments and Future Plans
    2.7 Bio Basic
        2.7.1 Bio Basic Details
        2.7.2 Bio Basic Major Business
        2.7.3 Bio Basic Peptide CDMO Product and Solutions
        2.7.4 Bio Basic Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Bio Basic Recent Developments and Future Plans
    2.8 JPT
        2.8.1 JPT Details
        2.8.2 JPT Major Business
        2.8.3 JPT Peptide CDMO Product and Solutions
        2.8.4 JPT Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 JPT Recent Developments and Future Plans
    2.9 Genscript
        2.9.1 Genscript Details
        2.9.2 Genscript Major Business
        2.9.3 Genscript Peptide CDMO Product and Solutions
        2.9.4 Genscript Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Genscript Recent Developments and Future Plans
    2.10 Xinbang Pharma
        2.10.1 Xinbang Pharma Details
        2.10.2 Xinbang Pharma Major Business
        2.10.3 Xinbang Pharma Peptide CDMO Product and Solutions
        2.10.4 Xinbang Pharma Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Xinbang Pharma Recent Developments and Future Plans
    2.11 ScinoPharm
        2.11.1 ScinoPharm Details
        2.11.2 ScinoPharm Major Business
        2.11.3 ScinoPharm Peptide CDMO Product and Solutions
        2.11.4 ScinoPharm Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 ScinoPharm Recent Developments and Future Plans
    2.12 SN Biopharm
        2.12.1 SN Biopharm Details
        2.12.2 SN Biopharm Major Business
        2.12.3 SN Biopharm Peptide CDMO Product and Solutions
        2.12.4 SN Biopharm Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 SN Biopharm Recent Developments and Future Plans
    2.13 CBL
        2.13.1 CBL Details
        2.13.2 CBL Major Business
        2.13.3 CBL Peptide CDMO Product and Solutions
        2.13.4 CBL Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 CBL Recent Developments and Future Plans
    2.14 Piramal Pharma
        2.14.1 Piramal Pharma Details
        2.14.2 Piramal Pharma Major Business
        2.14.3 Piramal Pharma Peptide CDMO Product and Solutions
        2.14.4 Piramal Pharma Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Piramal Pharma Recent Developments and Future Plans
    2.15 CPC Scientific
        2.15.1 CPC Scientific Details
        2.15.2 CPC Scientific Major Business
        2.15.3 CPC Scientific Peptide CDMO Product and Solutions
        2.15.4 CPC Scientific Peptide CDMO Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 CPC Scientific Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Peptide CDMO Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Peptide CDMO by Company Revenue
        3.2.2 Top 3 Peptide CDMO Players Market Share in 2022
        3.2.3 Top 6 Peptide CDMO Players Market Share in 2022
    3.3 Peptide CDMO Market: Overall Company Footprint Analysis
        3.3.1 Peptide CDMO Market: Region Footprint
        3.3.2 Peptide CDMO Market: Company Product Type Footprint
        3.3.3 Peptide CDMO Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Peptide CDMO Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Peptide CDMO Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Peptide CDMO Consumption Value Market Share by Application (2018-2023)
    5.2 Global Peptide CDMO Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Peptide CDMO Consumption Value by Type (2018-2029)
    6.2 North America Peptide CDMO Consumption Value by Application (2018-2029)
    6.3 North America Peptide CDMO Market Size by Country
        6.3.1 North America Peptide CDMO Consumption Value by Country (2018-2029)
        6.3.2 United States Peptide CDMO Market Size and Forecast (2018-2029)
        6.3.3 Canada Peptide CDMO Market Size and Forecast (2018-2029)
        6.3.4 Mexico Peptide CDMO Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Peptide CDMO Consumption Value by Type (2018-2029)
    7.2 Europe Peptide CDMO Consumption Value by Application (2018-2029)
    7.3 Europe Peptide CDMO Market Size by Country
        7.3.1 Europe Peptide CDMO Consumption Value by Country (2018-2029)
        7.3.2 Germany Peptide CDMO Market Size and Forecast (2018-2029)
        7.3.3 France Peptide CDMO Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Peptide CDMO Market Size and Forecast (2018-2029)
        7.3.5 Russia Peptide CDMO Market Size and Forecast (2018-2029)
        7.3.6 Italy Peptide CDMO Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Peptide CDMO Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Peptide CDMO Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Peptide CDMO Market Size by Region
        8.3.1 Asia-Pacific Peptide CDMO Consumption Value by Region (2018-2029)
        8.3.2 China Peptide CDMO Market Size and Forecast (2018-2029)
        8.3.3 Japan Peptide CDMO Market Size and Forecast (2018-2029)
        8.3.4 South Korea Peptide CDMO Market Size and Forecast (2018-2029)
        8.3.5 India Peptide CDMO Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Peptide CDMO Market Size and Forecast (2018-2029)
        8.3.7 Australia Peptide CDMO Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Peptide CDMO Consumption Value by Type (2018-2029)
    9.2 South America Peptide CDMO Consumption Value by Application (2018-2029)
    9.3 South America Peptide CDMO Market Size by Country
        9.3.1 South America Peptide CDMO Consumption Value by Country (2018-2029)
        9.3.2 Brazil Peptide CDMO Market Size and Forecast (2018-2029)
        9.3.3 Argentina Peptide CDMO Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Peptide CDMO Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Peptide CDMO Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Peptide CDMO Market Size by Country
        10.3.1 Middle East & Africa Peptide CDMO Consumption Value by Country (2018-2029)
        10.3.2 Turkey Peptide CDMO Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Peptide CDMO Market Size and Forecast (2018-2029)
        10.3.4 UAE Peptide CDMO Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Peptide CDMO Market Drivers
    11.2 Peptide CDMO Market Restraints
    11.3 Peptide CDMO Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Peptide CDMO Industry Chain
    12.2 Peptide CDMO Upstream Analysis
    12.3 Peptide CDMO Midstream Analysis
    12.4 Peptide CDMO Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Peptide CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Peptide CDMO Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Peptide CDMO Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Peptide CDMO Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Bachem Company Information, Head Office, and Major Competitors
    Table 6. Bachem Major Business
    Table 7. Bachem Peptide CDMO Product and Solutions
    Table 8. Bachem Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Bachem Recent Developments and Future Plans
    Table 10. PolyPeptide Company Information, Head Office, and Major Competitors
    Table 11. PolyPeptide Major Business
    Table 12. PolyPeptide Peptide CDMO Product and Solutions
    Table 13. PolyPeptide Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. PolyPeptide Recent Developments and Future Plans
    Table 15. CordenPharma Company Information, Head Office, and Major Competitors
    Table 16. CordenPharma Major Business
    Table 17. CordenPharma Peptide CDMO Product and Solutions
    Table 18. CordenPharma Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. CordenPharma Recent Developments and Future Plans
    Table 20. AmbioPharm Company Information, Head Office, and Major Competitors
    Table 21. AmbioPharm Major Business
    Table 22. AmbioPharm Peptide CDMO Product and Solutions
    Table 23. AmbioPharm Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. AmbioPharm Recent Developments and Future Plans
    Table 25. USV Peptides Company Information, Head Office, and Major Competitors
    Table 26. USV Peptides Major Business
    Table 27. USV Peptides Peptide CDMO Product and Solutions
    Table 28. USV Peptides Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. USV Peptides Recent Developments and Future Plans
    Table 30. Thermofischer Company Information, Head Office, and Major Competitors
    Table 31. Thermofischer Major Business
    Table 32. Thermofischer Peptide CDMO Product and Solutions
    Table 33. Thermofischer Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Thermofischer Recent Developments and Future Plans
    Table 35. Bio Basic Company Information, Head Office, and Major Competitors
    Table 36. Bio Basic Major Business
    Table 37. Bio Basic Peptide CDMO Product and Solutions
    Table 38. Bio Basic Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Bio Basic Recent Developments and Future Plans
    Table 40. JPT Company Information, Head Office, and Major Competitors
    Table 41. JPT Major Business
    Table 42. JPT Peptide CDMO Product and Solutions
    Table 43. JPT Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. JPT Recent Developments and Future Plans
    Table 45. Genscript Company Information, Head Office, and Major Competitors
    Table 46. Genscript Major Business
    Table 47. Genscript Peptide CDMO Product and Solutions
    Table 48. Genscript Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Genscript Recent Developments and Future Plans
    Table 50. Xinbang Pharma Company Information, Head Office, and Major Competitors
    Table 51. Xinbang Pharma Major Business
    Table 52. Xinbang Pharma Peptide CDMO Product and Solutions
    Table 53. Xinbang Pharma Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. Xinbang Pharma Recent Developments and Future Plans
    Table 55. ScinoPharm Company Information, Head Office, and Major Competitors
    Table 56. ScinoPharm Major Business
    Table 57. ScinoPharm Peptide CDMO Product and Solutions
    Table 58. ScinoPharm Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 59. ScinoPharm Recent Developments and Future Plans
    Table 60. SN Biopharm Company Information, Head Office, and Major Competitors
    Table 61. SN Biopharm Major Business
    Table 62. SN Biopharm Peptide CDMO Product and Solutions
    Table 63. SN Biopharm Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 64. SN Biopharm Recent Developments and Future Plans
    Table 65. CBL Company Information, Head Office, and Major Competitors
    Table 66. CBL Major Business
    Table 67. CBL Peptide CDMO Product and Solutions
    Table 68. CBL Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 69. CBL Recent Developments and Future Plans
    Table 70. Piramal Pharma Company Information, Head Office, and Major Competitors
    Table 71. Piramal Pharma Major Business
    Table 72. Piramal Pharma Peptide CDMO Product and Solutions
    Table 73. Piramal Pharma Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 74. Piramal Pharma Recent Developments and Future Plans
    Table 75. CPC Scientific Company Information, Head Office, and Major Competitors
    Table 76. CPC Scientific Major Business
    Table 77. CPC Scientific Peptide CDMO Product and Solutions
    Table 78. CPC Scientific Peptide CDMO Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 79. CPC Scientific Recent Developments and Future Plans
    Table 80. Global Peptide CDMO Revenue (USD Million) by Players (2018-2023)
    Table 81. Global Peptide CDMO Revenue Share by Players (2018-2023)
    Table 82. Breakdown of Peptide CDMO by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 83. Market Position of Players in Peptide CDMO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 84. Head Office of Key Peptide CDMO Players
    Table 85. Peptide CDMO Market: Company Product Type Footprint
    Table 86. Peptide CDMO Market: Company Product Application Footprint
    Table 87. Peptide CDMO New Market Entrants and Barriers to Market Entry
    Table 88. Peptide CDMO Mergers, Acquisition, Agreements, and Collaborations
    Table 89. Global Peptide CDMO Consumption Value (USD Million) by Type (2018-2023)
    Table 90. Global Peptide CDMO Consumption Value Share by Type (2018-2023)
    Table 91. Global Peptide CDMO Consumption Value Forecast by Type (2024-2029)
    Table 92. Global Peptide CDMO Consumption Value by Application (2018-2023)
    Table 93. Global Peptide CDMO Consumption Value Forecast by Application (2024-2029)
    Table 94. North America Peptide CDMO Consumption Value by Type (2018-2023) & (USD Million)
    Table 95. North America Peptide CDMO Consumption Value by Type (2024-2029) & (USD Million)
    Table 96. North America Peptide CDMO Consumption Value by Application (2018-2023) & (USD Million)
    Table 97. North America Peptide CDMO Consumption Value by Application (2024-2029) & (USD Million)
    Table 98. North America Peptide CDMO Consumption Value by Country (2018-2023) & (USD Million)
    Table 99. North America Peptide CDMO Consumption Value by Country (2024-2029) & (USD Million)
    Table 100. Europe Peptide CDMO Consumption Value by Type (2018-2023) & (USD Million)
    Table 101. Europe Peptide CDMO Consumption Value by Type (2024-2029) & (USD Million)
    Table 102. Europe Peptide CDMO Consumption Value by Application (2018-2023) & (USD Million)
    Table 103. Europe Peptide CDMO Consumption Value by Application (2024-2029) & (USD Million)
    Table 104. Europe Peptide CDMO Consumption Value by Country (2018-2023) & (USD Million)
    Table 105. Europe Peptide CDMO Consumption Value by Country (2024-2029) & (USD Million)
    Table 106. Asia-Pacific Peptide CDMO Consumption Value by Type (2018-2023) & (USD Million)
    Table 107. Asia-Pacific Peptide CDMO Consumption Value by Type (2024-2029) & (USD Million)
    Table 108. Asia-Pacific Peptide CDMO Consumption Value by Application (2018-2023) & (USD Million)
    Table 109. Asia-Pacific Peptide CDMO Consumption Value by Application (2024-2029) & (USD Million)
    Table 110. Asia-Pacific Peptide CDMO Consumption Value by Region (2018-2023) & (USD Million)
    Table 111. Asia-Pacific Peptide CDMO Consumption Value by Region (2024-2029) & (USD Million)
    Table 112. South America Peptide CDMO Consumption Value by Type (2018-2023) & (USD Million)
    Table 113. South America Peptide CDMO Consumption Value by Type (2024-2029) & (USD Million)
    Table 114. South America Peptide CDMO Consumption Value by Application (2018-2023) & (USD Million)
    Table 115. South America Peptide CDMO Consumption Value by Application (2024-2029) & (USD Million)
    Table 116. South America Peptide CDMO Consumption Value by Country (2018-2023) & (USD Million)
    Table 117. South America Peptide CDMO Consumption Value by Country (2024-2029) & (USD Million)
    Table 118. Middle East & Africa Peptide CDMO Consumption Value by Type (2018-2023) & (USD Million)
    Table 119. Middle East & Africa Peptide CDMO Consumption Value by Type (2024-2029) & (USD Million)
    Table 120. Middle East & Africa Peptide CDMO Consumption Value by Application (2018-2023) & (USD Million)
    Table 121. Middle East & Africa Peptide CDMO Consumption Value by Application (2024-2029) & (USD Million)
    Table 122. Middle East & Africa Peptide CDMO Consumption Value by Country (2018-2023) & (USD Million)
    Table 123. Middle East & Africa Peptide CDMO Consumption Value by Country (2024-2029) & (USD Million)
    Table 124. Peptide CDMO Raw Material
    Table 125. Key Suppliers of Peptide CDMO Raw Materials
List of Figures
    Figure 1. Peptide CDMO Picture
    Figure 2. Global Peptide CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Peptide CDMO Consumption Value Market Share by Type in 2022
    Figure 4. APIs and Intermediates
    Figure 5. FDF
    Figure 6. Global Peptide CDMO Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 7. Peptide CDMO Consumption Value Market Share by Application in 2022
    Figure 8. Commercial Picture
    Figure 9. Academic Research Picture
    Figure 10. Other Picture
    Figure 11. Global Peptide CDMO Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Peptide CDMO Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Market Peptide CDMO Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 14. Global Peptide CDMO Consumption Value Market Share by Region (2018-2029)
    Figure 15. Global Peptide CDMO Consumption Value Market Share by Region in 2022
    Figure 16. North America Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 17. Europe Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 18. Asia-Pacific Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 19. South America Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 20. Middle East and Africa Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 21. Global Peptide CDMO Revenue Share by Players in 2022
    Figure 22. Peptide CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 23. Global Top 3 Players Peptide CDMO Market Share in 2022
    Figure 24. Global Top 6 Players Peptide CDMO Market Share in 2022
    Figure 25. Global Peptide CDMO Consumption Value Share by Type (2018-2023)
    Figure 26. Global Peptide CDMO Market Share Forecast by Type (2024-2029)
    Figure 27. Global Peptide CDMO Consumption Value Share by Application (2018-2023)
    Figure 28. Global Peptide CDMO Market Share Forecast by Application (2024-2029)
    Figure 29. North America Peptide CDMO Consumption Value Market Share by Type (2018-2029)
    Figure 30. North America Peptide CDMO Consumption Value Market Share by Application (2018-2029)
    Figure 31. North America Peptide CDMO Consumption Value Market Share by Country (2018-2029)
    Figure 32. United States Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 33. Canada Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 34. Mexico Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 35. Europe Peptide CDMO Consumption Value Market Share by Type (2018-2029)
    Figure 36. Europe Peptide CDMO Consumption Value Market Share by Application (2018-2029)
    Figure 37. Europe Peptide CDMO Consumption Value Market Share by Country (2018-2029)
    Figure 38. Germany Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 39. France Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 40. United Kingdom Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 41. Russia Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 42. Italy Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 43. Asia-Pacific Peptide CDMO Consumption Value Market Share by Type (2018-2029)
    Figure 44. Asia-Pacific Peptide CDMO Consumption Value Market Share by Application (2018-2029)
    Figure 45. Asia-Pacific Peptide CDMO Consumption Value Market Share by Region (2018-2029)
    Figure 46. China Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 47. Japan Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 48. South Korea Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 49. India Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 50. Southeast Asia Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 51. Australia Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 52. South America Peptide CDMO Consumption Value Market Share by Type (2018-2029)
    Figure 53. South America Peptide CDMO Consumption Value Market Share by Application (2018-2029)
    Figure 54. South America Peptide CDMO Consumption Value Market Share by Country (2018-2029)
    Figure 55. Brazil Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 56. Argentina Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 57. Middle East and Africa Peptide CDMO Consumption Value Market Share by Type (2018-2029)
    Figure 58. Middle East and Africa Peptide CDMO Consumption Value Market Share by Application (2018-2029)
    Figure 59. Middle East and Africa Peptide CDMO Consumption Value Market Share by Country (2018-2029)
    Figure 60. Turkey Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 61. Saudi Arabia Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 62. UAE Peptide CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 63. Peptide CDMO Market Drivers
    Figure 64. Peptide CDMO Market Restraints
    Figure 65. Peptide CDMO Market Trends
    Figure 66. Porters Five Forces Analysis
    Figure 67. Manufacturing Cost Structure Analysis of Peptide CDMO in 2022
    Figure 68. Manufacturing Process Analysis of Peptide CDMO
    Figure 69. Peptide CDMO Industrial Chain
    Figure 70. Methodology
    Figure 71. Research Process and Data Source

Companies Mentioned

Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
Genscript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific